Discontinuation report AVANDIA
Report ID | 113311 |
Drug Identification Number | 02241112 |
Brand name | AVANDIA |
Common or Proper name | rosiglitazone (as rosiglitazone maleate) tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROSIGLITAZONE |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60's |
ATC code | A10BG |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-08-31 |
Actual discontinuation date | 2020-08-31 |
Remaining supply date | 2021-09-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-09-01 | French | Compare |
v5 | 2020-09-01 | English | Compare |
v4 | 2020-07-31 | French | Compare |
v3 | 2020-07-31 | English | Compare |
v2 | 2020-04-27 | French | Compare |
v1 | 2020-04-27 | English | Compare |
Showing 1 to 6 of 6